 | • レポートコード：QYR2104Z2266 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ユーイング肉腫治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビンクリスチン、シクロホスファミド、ドキソルビシン、エトポシド、イホスファミド、ダクチノマイシン）、用途別市場規模（病院、在宅ケア、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ユーイング肉腫治療薬の市場動向 ・企業の競争状況、市場シェア ・ユーイング肉腫治療薬の種類別市場規模（ビンクリスチン、シクロホスファミド、ドキソルビシン、エトポシド、イホスファミド、ダクチノマイシン） ・ユーイング肉腫治療薬の用途別市場規模（病院、在宅ケア、専門クリニック、その他） ・ユーイング肉腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ユーイング肉腫治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ユーイング肉腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ユーイング肉腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ユーイング肉腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Roche、GlaxoSmithKline、Novartis、Pfizer、Johnson & Johnson、Bristol-Myers Squibb、Sanofi、Abbott、Bausch Health、Eli Lilly、AbbVie、Takeda Pharmaceutical、Amgen、AstraZeneca、Eisai、Incyte Corporation） ・結論 |
Ewing sarcoma is a cancerous tumor that grows in the bones or in the tissue around bones (soft tissue)—often the legs, pelvis, ribs, arms or spine. Ewing sarcoma can spread to the lungs, bones and bone marrow.
Market Analysis and Insights: Global Ewing Sarcoma Drugs Market
The global Ewing Sarcoma Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ewing Sarcoma Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ewing Sarcoma Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ewing Sarcoma Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ewing Sarcoma Drugs market.
Global Ewing Sarcoma Drugs Scope and Market Size
Ewing Sarcoma Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ewing Sarcoma Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Vincristine
Cyclophosphamide
Doxorubicin
Etoposide
Ifosfamide
Dactinomycin
Segment by Application
Hospitals
Homecare
Specialty Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Roche
GlaxoSmithKline
Novartis
Pfizer
Johnson & Johnson
Bristol-Myers Squibb
Sanofi
Abbott
Novartis
Pfizer
AbbVie
Takeda Pharmaceutical
Amgen
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ewing Sarcoma Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vincristine
1.2.3 Cyclophosphamide
1.2.4 Doxorubicin
1.2.5 Etoposide
1.2.6 Ifosfamide
1.2.7 Dactinomycin
1.3 Market by Application
1.3.1 Global Ewing Sarcoma Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ewing Sarcoma Drugs Market Perspective (2016-2027)
2.2 Ewing Sarcoma Drugs Growth Trends by Regions
2.2.1 Ewing Sarcoma Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ewing Sarcoma Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Ewing Sarcoma Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Ewing Sarcoma Drugs Industry Dynamic
2.3.1 Ewing Sarcoma Drugs Market Trends
2.3.2 Ewing Sarcoma Drugs Market Drivers
2.3.3 Ewing Sarcoma Drugs Market Challenges
2.3.4 Ewing Sarcoma Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ewing Sarcoma Drugs Players by Revenue
3.1.1 Global Top Ewing Sarcoma Drugs Players by Revenue (2016-2021)
3.1.2 Global Ewing Sarcoma Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Ewing Sarcoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ewing Sarcoma Drugs Revenue
3.4 Global Ewing Sarcoma Drugs Market Concentration Ratio
3.4.1 Global Ewing Sarcoma Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ewing Sarcoma Drugs Revenue in 2020
3.5 Ewing Sarcoma Drugs Key Players Head office and Area Served
3.6 Key Players Ewing Sarcoma Drugs Product Solution and Service
3.7 Date of Enter into Ewing Sarcoma Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ewing Sarcoma Drugs Breakdown Data by Type
4.1 Global Ewing Sarcoma Drugs Historic Market Size by Type (2016-2021)
4.2 Global Ewing Sarcoma Drugs Forecasted Market Size by Type (2022-2027)
5 Ewing Sarcoma Drugs Breakdown Data by Application
5.1 Global Ewing Sarcoma Drugs Historic Market Size by Application (2016-2021)
5.2 Global Ewing Sarcoma Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ewing Sarcoma Drugs Market Size (2016-2027)
6.2 North America Ewing Sarcoma Drugs Market Size by Type
6.2.1 North America Ewing Sarcoma Drugs Market Size by Type (2016-2021)
6.2.2 North America Ewing Sarcoma Drugs Market Size by Type (2022-2027)
6.2.3 North America Ewing Sarcoma Drugs Market Size by Type (2016-2027)
6.3 North America Ewing Sarcoma Drugs Market Size by Application
6.3.1 North America Ewing Sarcoma Drugs Market Size by Application (2016-2021)
6.3.2 North America Ewing Sarcoma Drugs Market Size by Application (2022-2027)
6.3.3 North America Ewing Sarcoma Drugs Market Size by Application (2016-2027)
6.4 North America Ewing Sarcoma Drugs Market Size by Country
6.4.1 North America Ewing Sarcoma Drugs Market Size by Country (2016-2021)
6.4.2 North America Ewing Sarcoma Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ewing Sarcoma Drugs Market Size (2016-2027)
7.2 Europe Ewing Sarcoma Drugs Market Size by Type
7.2.1 Europe Ewing Sarcoma Drugs Market Size by Type (2016-2021)
7.2.2 Europe Ewing Sarcoma Drugs Market Size by Type (2022-2027)
7.2.3 Europe Ewing Sarcoma Drugs Market Size by Type (2016-2027)
7.3 Europe Ewing Sarcoma Drugs Market Size by Application
7.3.1 Europe Ewing Sarcoma Drugs Market Size by Application (2016-2021)
7.3.2 Europe Ewing Sarcoma Drugs Market Size by Application (2022-2027)
7.3.3 Europe Ewing Sarcoma Drugs Market Size by Application (2016-2027)
7.4 Europe Ewing Sarcoma Drugs Market Size by Country
7.4.1 Europe Ewing Sarcoma Drugs Market Size by Country (2016-2021)
7.4.2 Europe Ewing Sarcoma Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ewing Sarcoma Drugs Market Size (2016-2027)
8.2 Asia-Pacific Ewing Sarcoma Drugs Market Size by Type
8.2.1 Asia-Pacific Ewing Sarcoma Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ewing Sarcoma Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ewing Sarcoma Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Ewing Sarcoma Drugs Market Size by Application
8.3.1 Asia-Pacific Ewing Sarcoma Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ewing Sarcoma Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ewing Sarcoma Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Ewing Sarcoma Drugs Market Size by Region
8.4.1 Asia-Pacific Ewing Sarcoma Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ewing Sarcoma Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ewing Sarcoma Drugs Market Size (2016-2027)
9.2 Latin America Ewing Sarcoma Drugs Market Size by Type
9.2.1 Latin America Ewing Sarcoma Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Ewing Sarcoma Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Ewing Sarcoma Drugs Market Size by Type (2016-2027)
9.3 Latin America Ewing Sarcoma Drugs Market Size by Application
9.3.1 Latin America Ewing Sarcoma Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Ewing Sarcoma Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Ewing Sarcoma Drugs Market Size by Application (2016-2027)
9.4 Latin America Ewing Sarcoma Drugs Market Size by Country
9.4.1 Latin America Ewing Sarcoma Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Ewing Sarcoma Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ewing Sarcoma Drugs Market Size (2016-2027)
10.2 Middle East & Africa Ewing Sarcoma Drugs Market Size by Type
10.2.1 Middle East & Africa Ewing Sarcoma Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ewing Sarcoma Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ewing Sarcoma Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Ewing Sarcoma Drugs Market Size by Application
10.3.1 Middle East & Africa Ewing Sarcoma Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ewing Sarcoma Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ewing Sarcoma Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Ewing Sarcoma Drugs Market Size by Country
10.4.1 Middle East & Africa Ewing Sarcoma Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ewing Sarcoma Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Ewing Sarcoma Drugs Introduction
11.1.4 Merck Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Ewing Sarcoma Drugs Introduction
11.2.4 Roche Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.2.5 Roche Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Ewing Sarcoma Drugs Introduction
11.3.4 GlaxoSmithKline Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Ewing Sarcoma Drugs Introduction
11.4.4 Novartis Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Ewing Sarcoma Drugs Introduction
11.5.4 Pfizer Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Ewing Sarcoma Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Ewing Sarcoma Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Ewing Sarcoma Drugs Introduction
11.8.4 Sanofi Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Ewing Sarcoma Drugs Introduction
11.9.4 Abbott Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.9.5 Abbott Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Details
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Ewing Sarcoma Drugs Introduction
11.10.4 Bausch Health Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.10.5 Bausch Health Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Ewing Sarcoma Drugs Introduction
11.11.4 Eli Lilly Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 AbbVie
11.12.1 AbbVie Company Details
11.12.2 AbbVie Business Overview
11.12.3 AbbVie Ewing Sarcoma Drugs Introduction
11.12.4 AbbVie Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.12.5 AbbVie Recent Development
11.13 Takeda Pharmaceutical
11.13.1 Takeda Pharmaceutical Company Details
11.13.2 Takeda Pharmaceutical Business Overview
11.13.3 Takeda Pharmaceutical Ewing Sarcoma Drugs Introduction
11.13.4 Takeda Pharmaceutical Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.13.5 Takeda Pharmaceutical Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Ewing Sarcoma Drugs Introduction
11.14.4 Amgen Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.14.5 Amgen Recent Development
11.15 AstraZeneca
11.15.1 AstraZeneca Company Details
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Ewing Sarcoma Drugs Introduction
11.15.4 AstraZeneca Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.15.5 AstraZeneca Recent Development
11.16 Eisai
11.16.1 Eisai Company Details
11.16.2 Eisai Business Overview
11.16.3 Eisai Ewing Sarcoma Drugs Introduction
11.16.4 Eisai Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.16.5 Eisai Recent Development
11.17 Incyte Corporation
11.17.1 Incyte Corporation Company Details
11.17.2 Incyte Corporation Business Overview
11.17.3 Incyte Corporation Ewing Sarcoma Drugs Introduction
11.17.4 Incyte Corporation Revenue in Ewing Sarcoma Drugs Business (2016-2021)
11.17.5 Incyte Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ewing Sarcoma Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vincristine
Table 3. Key Players of Cyclophosphamide
Table 4. Key Players of Doxorubicin
Table 5. Key Players of Etoposide
Table 6. Key Players of Ifosfamide
Table 7. Key Players of Dactinomycin
Table 8. Global Ewing Sarcoma Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ewing Sarcoma Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Ewing Sarcoma Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Ewing Sarcoma Drugs Market Share by Regions (2016-2021)
Table 12. Global Ewing Sarcoma Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Ewing Sarcoma Drugs Market Share by Regions (2022-2027)
Table 14. Ewing Sarcoma Drugs Market Trends
Table 15. Ewing Sarcoma Drugs Market Drivers
Table 16. Ewing Sarcoma Drugs Market Challenges
Table 17. Ewing Sarcoma Drugs Market Restraints
Table 18. Global Ewing Sarcoma Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Ewing Sarcoma Drugs Market Share by Players (2016-2021)
Table 20. Global Top Ewing Sarcoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ewing Sarcoma Drugs as of 2020)
Table 21. Ranking of Global Top Ewing Sarcoma Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Ewing Sarcoma Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Ewing Sarcoma Drugs Product Solution and Service
Table 25. Date of Enter into Ewing Sarcoma Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ewing Sarcoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Ewing Sarcoma Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Ewing Sarcoma Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Ewing Sarcoma Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Ewing Sarcoma Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Ewing Sarcoma Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Ewing Sarcoma Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Ewing Sarcoma Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Ewing Sarcoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Ewing Sarcoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Ewing Sarcoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Ewing Sarcoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Ewing Sarcoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Ewing Sarcoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Ewing Sarcoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Ewing Sarcoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Ewing Sarcoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Ewing Sarcoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Ewing Sarcoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Ewing Sarcoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ewing Sarcoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ewing Sarcoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ewing Sarcoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Ewing Sarcoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Ewing Sarcoma Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Ewing Sarcoma Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Ewing Sarcoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Ewing Sarcoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Ewing Sarcoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Ewing Sarcoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Ewing Sarcoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Ewing Sarcoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ewing Sarcoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ewing Sarcoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ewing Sarcoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Ewing Sarcoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Ewing Sarcoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Ewing Sarcoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Ewing Sarcoma Drugs Product
Table 68. Merck Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Ewing Sarcoma Drugs Product
Table 73. Roche Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 74. Roche Recent Development
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Ewing Sarcoma Drugs Product
Table 78. GlaxoSmithKline Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Ewing Sarcoma Drugs Product
Table 83. Novartis Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Ewing Sarcoma Drugs Product
Table 88. Pfizer Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Ewing Sarcoma Drugs Product
Table 93. Johnson & Johnson Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 94. Johnson & Johnson Recent Development
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb Ewing Sarcoma Drugs Product
Table 98. Bristol-Myers Squibb Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Abbott Company Details
Table 105. Abbott Business Overview
Table 106. Abbott Ewing Sarcoma Drugs Product
Table 107. Abbott Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 108. Abbott Recent Development
Table 109. Bausch Health Company Details
Table 110. Bausch Health Business Overview
Table 111. Bausch Health Ewing Sarcoma Drugs Product
Table 112. Bausch Health Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 113. Bausch Health Recent Development
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Ewing Sarcoma Drugs Product
Table 117. Eli Lilly Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 118. Eli Lilly Recent Development
Table 119. AbbVie Company Details
Table 120. AbbVie Business Overview
Table 121. AbbVie Ewing Sarcoma Drugs Product
Table 122. AbbVie Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 123. AbbVie Recent Development
Table 124. Takeda Pharmaceutical Company Details
Table 125. Takeda Pharmaceutical Business Overview
Table 126. Takeda Pharmaceutical Ewing Sarcoma Drugs Product
Table 127. Takeda Pharmaceutical Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 128. Takeda Pharmaceutical Recent Development
Table 129. Amgen Company Details
Table 130. Amgen Business Overview
Table 131. Amgen Ewing Sarcoma Drugs Product
Table 132. Amgen Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 133. Amgen Recent Development
Table 134. AstraZeneca Company Details
Table 135. AstraZeneca Business Overview
Table 136. AstraZeneca Ewing Sarcoma Drugs Product
Table 137. AstraZeneca Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 138. AstraZeneca Recent Development
Table 139. Eisai Company Details
Table 140. Eisai Business Overview
Table 141. Eisai Ewing Sarcoma Drugs Product
Table 142. Eisai Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 143. Eisai Recent Development
Table 144. Incyte Corporation Company Details
Table 145. Incyte Corporation Business Overview
Table 146. Incyte Corporation Ewing Sarcoma Drugs Product
Table 147. Incyte Corporation Revenue in Ewing Sarcoma Drugs Business (2016-2021) & (US$ Million)
Table 148. Incyte Corporation Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ewing Sarcoma Drugs Market Share by Type: 2020 VS 2027
Figure 2. Vincristine Features
Figure 3. Cyclophosphamide Features
Figure 4. Doxorubicin Features
Figure 5. Etoposide Features
Figure 6. Ifosfamide Features
Figure 7. Dactinomycin Features
Figure 8. Global Ewing Sarcoma Drugs Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Homecare Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Ewing Sarcoma Drugs Report Years Considered
Figure 14. Global Ewing Sarcoma Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Ewing Sarcoma Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Ewing Sarcoma Drugs Market Share by Regions: 2020 VS 2027
Figure 17. Global Ewing Sarcoma Drugs Market Share by Regions (2022-2027)
Figure 18. Global Ewing Sarcoma Drugs Market Share by Players in 2020
Figure 19. Global Top Ewing Sarcoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ewing Sarcoma Drugs as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Ewing Sarcoma Drugs Revenue in 2020
Figure 21. Global Ewing Sarcoma Drugs Revenue Market Share by Type (2016-2021)
Figure 22. Global Ewing Sarcoma Drugs Revenue Market Share by Type (2022-2027)
Figure 23. North America Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Ewing Sarcoma Drugs Market Share by Type (2016-2027)
Figure 25. North America Ewing Sarcoma Drugs Market Share by Application (2016-2027)
Figure 26. North America Ewing Sarcoma Drugs Market Share by Country (2016-2027)
Figure 27. United States Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Ewing Sarcoma Drugs Market Share by Type (2016-2027)
Figure 31. Europe Ewing Sarcoma Drugs Market Share by Application (2016-2027)
Figure 32. Europe Ewing Sarcoma Drugs Market Share by Country (2016-2027)
Figure 33. Germany Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Ewing Sarcoma Drugs Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Ewing Sarcoma Drugs Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Ewing Sarcoma Drugs Market Share by Region (2016-2027)
Figure 43. China Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Ewing Sarcoma Drugs Market Share by Type (2016-2027)
Figure 51. Latin America Ewing Sarcoma Drugs Market Share by Application (2016-2027)
Figure 52. Latin America Ewing Sarcoma Drugs Market Share by Country (2016-2027)
Figure 53. Mexico Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Ewing Sarcoma Drugs Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Ewing Sarcoma Drugs Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Ewing Sarcoma Drugs Market Share by Country (2016-2027)
Figure 59. Turkey Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Ewing Sarcoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Merck Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 70. Abbott Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 71. Bausch Health Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 72. Eli Lilly Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 73. AbbVie Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 74. Takeda Pharmaceutical Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 75. Amgen Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 76. AstraZeneca Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 77. Eisai Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 78. Incyte Corporation Revenue Growth Rate in Ewing Sarcoma Drugs Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界のカポジ肉腫市場規模・現状・予測（2021年-2027年） Kaposi's sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised. Four sub-ty…- 世界の軟部肉腫治療市場規模・現状・予測（2021年-2027年） Sarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Increasing cases of soft tissue sarcoma and different types of cancer are expected to boost the growth for soft tissue sarcoma market. Market Analysis and Insights: Global So…
- 世界のビンクリスチン硫酸塩リポソーム注射薬市場 2021：企業別、地域別、種類・用途別 The Vincristine Sulfate Liposome Injection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の自己免疫治療薬市場規模・現状・予測（2021年-2027年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 世界のドライアイ症候群治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dry Eye Syndrome Drugs Market The global Dry Eye Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…